Archives
- 2026-09
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
-
GDC-0941 as a PI3K/Akt Dependency Probe
2026-09-19
GDC-0941 is a selective PI3K inhibitor for testing how PI3K/Akt signaling sustains cancer-cell survival, therapy resistance, and stem-like phenotypes. This article connects its pharmacology with the DRD4–Akt–β-catenin model in liver cancer and shows how to choose mechanistically informative assay readouts.
-
Angiotensin Peptides and SARS-CoV-2 Receptor Binding
2026-09-18
A 2025 study found that naturally occurring angiotensin peptides can increase SARS-CoV-2 spike-protein binding to host receptors, with especially strong effects associated with shorter peptides and angiotensin IV. The work links renin–angiotensin system peptide processing to a biochemical step in viral entry while emphasizing that receptor-binding results do not by themselves establish effects on infection or disease severity.
-
Leucovorin Calcium in Gastric Cancer Assays
2026-09-17
Leucovorin Calcium, or calcium folinate, can serve as more than a methotrexate rescue reagent. This article explains how to use its folate-bypass biology as an interpretive control in patient-derived gastric cancer assembloid assays and tumor–stroma resistance studies.
-
TRIM66 and Monogenic Olfactory Receptor Expression
2026-09-17
The reference study identifies TRIM66 as an epigenetic repressor that helps convert initially polygenic olfactory receptor transcription into stable monogenic expression in mature olfactory sensory neurons. By connecting enhancer repression with neural activity and innate olfactory behavior, the work supplies a mechanistic link between receptor-gene choice and sensory function.
-
Mitoxantrone, ABCG2, and Translational Leverage
2026-09-16
Mitoxantrone’s topoisomerase II activity is only the first layer of translational performance. This article connects DNA damage biology with ABCG2-mediated efflux, marein-based chemosensitization, assay design, and research-use considerations for oncology and orthopoxvirus models.
-
LNP Surface Charge and V-ATPase Drive Tropism
2026-09-16
The reference study proposes that lipid nanoparticle tropism is jointly determined by LNP surface charge and the V-ATPase activity of recipient cells. Its in vitro, in vivo, perturbation, and protein-corona analyses suggest that delivery cannot be understood from nanoparticle composition alone; the endo/lysosomal state of the target is also a major determinant.
-
From dNTP Fidelity to Smarter Nucleic Acid Translation
2026-09-15
Translational success in nucleic acid research depends on controlling both molecular building blocks and cellular delivery context. This article connects the reproducibility of an equimolar 10 mM dNTP mixture with emerging evidence that LNP surface charge and target-cell V-ATPase activity jointly influence nucleic acid delivery, while clearly separating established reagent performance from an emerging cross-domain hypothesis.
-
Multianimal MRI for Pancreatic Cancer Tumor Monitoring
2026-09-15
Kempinska and colleagues present a four-chamber MRI workflow that enables high-resolution anatomical imaging of multiple KPC mice in one acquisition session. The protocol reduces imaging burden while supporting tumor enrollment, longitudinal growth monitoring, and proof-of-concept assessment of gemcitabine treatment response.
-
Pulmonary Arterial Remodeling and RV Afterload
2026-09-14
The reference study uses a subject-specific one-dimensional fluid–structure interaction model to separate how distal resistance and arterial compliance contribute to pulmonary hypertension hemodynamics. Its findings indicate that increased distal resistance primarily elevates maximum main pulmonary artery pressure, whereas reduced compliance substantially increases characteristic impedance, offering a mechanistic framework for interpreting right-ventricular afterload.
-
Ginsenoside Rg1 Neuroimmune Research Workflow
2026-09-14
Build a reproducible Ginsenoside Rg1 workflow that connects behavior, cytokines, synaptic physiology, gut-barrier integrity, and regulatory T-cell biology. The approach translates a recent anesthesia model into practical neuroprotection research, with formulation controls and troubleshooting guidance for mechanistic studies.
-
Leucovorin Calcium in Gastric Cancer Assays
2026-09-13
Leucovorin Calcium enables controlled studies of methotrexate rescue, folate biology, and antifolate response in organoid and assembloid systems. This workflow shows how matched tumor–stroma models can distinguish cell-intrinsic rescue from microenvironment-dependent drug resistance.
-
Angiotensin Peptides and SARS-CoV-2 Receptor Binding
2026-09-12
Oliveira and colleagues report that naturally occurring angiotensin peptides can increase SARS-CoV-2 spike-protein binding to host receptors, with the strongest effects associated with selected shorter peptides and modifications around tyrosine. The work connects renin–angiotensin system biology with viral receptor engagement, while its binding-focused design calls for cautious interpretation beyond biochemical assays.
-
Leucovorin Calcium in Gastric Cancer Assembloids
2026-09-12
Explore how Leucovorin Calcium, or calcium folinate, can function as a mechanistic rescue control in patient-derived gastric cancer assembloid assays. This article connects folate biology with tumor–stroma-dependent drug response and provides a framework for interpreting methotrexate rescue data.
-
WM-8014: A Practical KAT6A Inhibitor Workflow
2026-09-11
WM-8014 combines reversible, competitive acetyl-CoA-site inhibition with a useful KAT6A/KAT6B selectivity window for studying cell-cycle arrest and senescence. This guide translates time-gated CRISPR findings into practical pharmacological workflows for epigenetic and cancer biology research, with assay design and troubleshooting guidance.
-
3-Hydroxybutyrate (BHBA): From Ketosis to Stroke
2026-09-11
3-hydroxybutyrate (BHBA) is more than an alternative fuel: it is a ketone body signaling molecule and class I HDAC inhibitor with potential relevance to ferroptosis, neuronal stress, and translational stroke research. This article connects the mechanistic evidence from remote ischemic postconditioning with practical experimental strategy and product selection.